Dramatic Hike Seen in Employee Health Insurance Costs

(MedPage Today) — Health insurance deductibles for people in employer-sponsored plans rose an average 77% between 2003 and 2009, while premiums for family coverage increased by 41%, the Commonwealth Fund reported.

FDA Adds Guidance to Two Class I Recalls

WASHINGTON (MedPage Today) — The FDA issued new guidance on two class I product recalls — the agency’s most serious — that carry potential fatal side effects for patients.

FDA Panel Rejects Prostate Drugs for CA Prevention

(MedPage Today) — SILVER SPRING, Md. — An FDA advisory panel has voted overwhelmingly that GlaxoSmithKline’s dutasteride (Avodart) and Merck’s finasteride (Proscar) should not be used to prevent prostate cancer because the drugs are linked to a higher incidence of high-grade tumors.

‘Don’t Ask, Don’t Tell’ Called Bad Health Policy

(MedPage Today) — The military’s “don’t ask, don’t tell” policy for gay, lesbian, and bisexual service members is not only a constitutional and legal issue — it also has serious health implications, an epidemiologist claims.

Residents Harbor Mixed Feelings on Duty-Hour Changes (CME/CE)

(MedPage Today) — Resident physicians look forward to better quality of life under the duty-hour restrictions due to take effect in 2011, but have mixed feelings about effects on their education and patient safety, according to a national survey.

Another Court Upholds Healthcare Reform Law

(MedPage Today) — A federal judge has dismissed a lawsuit filed by Liberty University, ruling that the healthcare reform law’s individual and employer mandates are constitutional under the Commerce Clause.

FDA Panel May Expand Lap-Band to Smaller Waists

WASHINGTON (MedPage Today) — The Lap-Band is a safe and effective weight-loss option for people who are less overweight than those who currently have the stomach-constricting device surgically implanted.

Novel Epilepsy Drug Faces Approval Delay

(MedPage Today) — The FDA has declined to let the investigational epilepsy drug ezogabine onto the U.S. market for now, even though an advisory committee voted unanimously in August to recommend approval.

FDA Adds Guidance to Two Class I Recalls

WASHINGTON (MedPage Today) — The FDA issued new guidance on two class I product recalls — the agency’s most serious — that carry potential fatal side effects for patients.

FDA Panel May Expand Lap-Band to Smaller Waists

WASHINGTON (MedPage Today) — The Lap-Band is a safe and effective weight-loss option for people who are less overweight than those who currently have the stomach-constricting device surgically implanted.